NOVAN
  • contact@novan.com
  • Morrisville, NC
  • 1.919.485.8080
  • Home
  • About Us
    • Our Science
      • Nitric Oxide
      • Conditions
      • Safety
    • Our People
      • Leadership
      • Board of Directors
      • Scientific Advisors
    • Careers
  • Research & Development
    • Technology
    • Pipeline
    • Publications
  • For Investors
    • Press Releases
    • SEC Filings
    • Events
    • Stock Information
    • Presentations
    • Analyst Coverage
    • Corporate Governance
    • Contact IR
    • E-mail Alerts
NOVAN
  • About Us
    • Our Science
      • Nitric oxide
      • Conditions
      • Safety
    • Our People
      • Leadership
      • Scientific Advisors
      • Board of Directors
    • Careers
  • Research & Development
    • Our Technology
    • Our Pipeline
    • Our Publications
  • For Investors
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
  • Research & Development
  • Technology
  • Pipeline
  • Publications

Publications

  • Research & Development
  • Technology
  • Pipeline

Novan’s team of top-tier scientists has published extensively about the safety and efficacy of nitric oxide, in leading medical publications like the Journal of Drugs in Dermatology, the American Society for Microbiology, and the Journal of Clinical and Aesthetic Dermatology.

Year
Title
2020

A Nitric Oxide-releasing Topical Medication as a Potential Treatment Option for Atopic Dermatitis Through Antimicrobial and Anti-inflammatory Activity

2019

Efficacy and Tolerability of an Investigational Nitric Oxide-releasing Topical Gel in Patients With Molluscum Contagiosum: A Randomized Clinical Trial

2019

NVN1000, a Novel Nitric Oxide-Releasing Compound, Inhibits HPV-18 Virus Production by Interfering with E6 and E7 Oncoprotein Functions

2018

A Phase 2, Controlled, Dose-Ranging Study of SB208, an Investigational Topical Nitric Oxide-Releasing Drug, for the Treatment of Tinea Pedis

2018

Nitric Oxide-Releasing Macromolecule Exhibits Broad-Spectrum Antifungal Activity and Utility as a Topical Treatment for Superficial Fungal Infections

2018

A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment

2016

Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulgaris

2016

Results of a Phase 2 Efficacy and Safety Study with SB204, an Investigational Topical Nitric Oxide-releasing Drug for the Treatment of Acne Vulgaris

NOVAN
  • 4105 Hopson Road
    Morrisville, NC 27560
  • phone: 1-919-485-8080
    email: contact@novan.com
  • About Us
  • Our Science
  • Our People
  • Careers
  • Research & Development
  • Our Technology
  • Our Pipeline
  • For Investors
  • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Corporate Governance

Copyright © 2012-2021 Novan, Inc. All rights reserved. Use of this website is governed by our Privacy Policy. See Terms of Use.

This website uses cookies to improve your experience. You can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.